Literature DB >> 3949412

Measurement of specific IgG antibody levels in serum of patients on regimes comprising high total dose beta-lactam therapy.

D Lee, J M Dewdney, R G Edwards, K A Neftel, M Wälti.   

Abstract

Sera from 125 patients receiving mean total doses of beta-lactam therapy of 215 g over a mean of 14 days were assayed by radioimmunoassay. Titres of anti-penicilloyl antibodies, expressed in arbitrary units of specific IgG per microliter of serum (u/microliter), ranged from undetectable (less than 3 u/microliter) to 1,650 u/microliter. There was a higher prevalence of elevated IgG levels in patients who developed haemolytic anaemia or neutropenia compared with patients with no adverse reactions but only in those patients who developed haemolytic anaemia were the antibody titres significantly higher. A subsidiary finding was that a correlation was established between mean total dose and prevalence of positive IgG titres, on a patient group basis (r = 0.87).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949412     DOI: 10.1159/000234000

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  3 in total

1.  Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin.

Authors:  Thomas Wendland; Barbara Daubner; Werner J Pichler
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

2.  A survey of the prevalence of penicillin-specific IgG, IgM and IgE antibodies detected by ELISA and defined by hapten inhibition, in patients with suspected penicillin allergy and in healthy volunteers.

Authors:  G Christie; J W Coleman; S Newby; A McDiarmaid-Gordon; J P Hampson; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

Review 3.  [Evaluation of hematologic side effects of anti-infective therapy: agranulocytosis caused by beta-lactam antibiotics, vancomycin and amodiaquine].

Authors:  G Eich; K A Neftel
Journal:  Infection       Date:  1991       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.